Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:focusesOn |
life sciences investments
healthcare investments |
| gptkbp:formerName |
Lumira Capital
|
| gptkbp:foundedIn |
1989
|
| gptkbp:headquartersLocation |
gptkb:Toronto,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lumira Ventures
|
| gptkbp:investedIn |
biotechnology companies
medical device companies healthcare IT companies |
| gptkbp:managingPartner |
gptkb:Peter_van_der_Velden
David MacNaughtan Gerry Brunk Jean-François Pariseau |
| gptkbp:notableInvestment |
gptkb:GenePOC
gptkb:Corvidia_Therapeutics Antios Therapeutics Kaleido Biosciences |
| gptkbp:officeLocation |
gptkb:Montreal,_Canada
gptkb:Vancouver,_Canada gptkb:Boston,_USA |
| gptkbp:regionServed |
gptkb:North_America
|
| gptkbp:website |
https://www.lumiraventures.com/
|
| gptkbp:bfsParent |
gptkb:Antiva_Biosciences
|
| gptkbp:bfsLayer |
8
|